EYPT — Eyepoint Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Eyepoint Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	44.9	212	145	331	371
Net Total Accounts Receivable
Net Total Receivables	9.45	18.4	15.5	0.805	0.607
Total Inventory
Prepaid Expenses
Total Current Assets	63.1	238	173	345	383
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.24	2.73	7.4	10.2	29.2
Net Intangible Assets
Other Long Term Assets
Total Assets	91.7	263	180	355	418
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14.9	23.7	34.5	63.3	49
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	73.2	79	84	88.9	82
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	18.5	184	96.4	266	337
Total Liabilities & Shareholders' Equity	91.7	263	180	355	418
Total Common Shares Outstanding